US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...

A clinical trial showed CAR-T cell therapy may shrink aggressive brain and spinal cord tumours in young patients.

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

KNOXVILLE, Tenn. (WATE) — Chris Patterson was a Knoxville fire captain when he rescued a woman from a house fire in December ...

"The technology's responsiveness to individual pain levels and real-time adaptation to patient needs ... Nevro's ...

The company announced receiving CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system ... such as ...

Scientists developed a genetic tool that can quickly identify nearly any type of pathogenic infection, including those caused ...

The company is facing significant headwinds in its U.S. core Spinal Cord Stimulation (SCS) market, where sales have continued to decline and trials have decelerated, raising concerns about the company ...

The Bedale-based Irishman has since been identified as having an unstable cervical fracture causing damage to his spinal cord ...

The global spinal fusion market is on track for substantial expansion, with recent projections highlighting a significant surge in its valuation. According to the latest market analysis, the spinal ...

While teaching his younger cousins how to dive into the sea Seb hit his head on the seabed, causing permanent damage to his ...